Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    20828991 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Curcumin as a Novel Treatment to Improve Cognitive Dysfunction in Schizophrenia
Conditions: Schizophrenia;   Cognition;   Psychosis
Intervention: Drug: Curcumin

Study has passed its completion date and status has not been verified in more than two years.